These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19234226)

  • 1. End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas.
    Robinson RT; Wang J; Cripps JG; Milks MW; English KA; Pearson TA; Gorham JD
    J Immunol; 2009 Mar; 182(5):3278-84. PubMed ID: 19234226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
    Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
    Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
    Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
    Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver.
    Cripps JG; Wang J; Maria A; Blumenthal I; Gorham JD
    Hepatology; 2010 Oct; 52(4):1350-9. PubMed ID: 20803559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease.
    Ramirez-Montagut T; Chow A; Kochman AA; Smith OM; Suh D; Sindhi H; Lu S; Borsotti C; Grubin J; Patel N; Terwey TH; Kim TD; Heller G; Murphy GF; Liu C; Alpdogan O; van den Brink MR
    J Immunol; 2007 Aug; 179(3):1669-80. PubMed ID: 17641033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells.
    Roth E; Pircher H
    J Immunol; 2004 Feb; 172(3):1588-94. PubMed ID: 14734739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.
    Cripps JG; Celaj S; Burdick M; Strieter RM; Gorham JD
    Lab Invest; 2012 Oct; 92(10):1461-71. PubMed ID: 22906987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis.
    Derkow K; Loddenkemper C; Mintern J; Kruse N; Klugewitz K; Berg T; Wiedenmann B; Ploegh HL; Schott E
    Hepatology; 2007 Oct; 46(4):1155-65. PubMed ID: 17657820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.
    Villegas-Mendez A; Greig R; Shaw TN; de Souza JB; Gwyer Findlay E; Stumhofer JS; Hafalla JC; Blount DG; Hunter CA; Riley EM; Couper KN
    J Immunol; 2012 Jul; 189(2):968-79. PubMed ID: 22723523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TNF-alpha produced by nonantigen-specific cells in a fulminant hepatitis mouse model.
    Ito H; Ando K; Ishikawa T; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
    J Immunol; 2009 Jan; 182(1):391-7. PubMed ID: 19109170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis.
    Milks MW; Cripps JG; Lin H; Wang J; Robinson RT; Sargent JL; Whitfield ML; Gorham JD
    Liver Int; 2009 Oct; 29(9):1307-15. PubMed ID: 19490417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel model of antigen-specific induction of bile duct injury.
    Buxbaum J; Qian P; Khuu C; Shneider BL; Daikh DI; Gershwin ME; Allen PM; Peters MG
    Gastroenterology; 2006 Dec; 131(6):1899-906. PubMed ID: 17087941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma expressed by T cells regulates the persistence of antigen presentation by limiting the survival of dendritic cells.
    Russell MS; Dudani R; Krishnan L; Sad S
    J Immunol; 2009 Dec; 183(12):7710-8. PubMed ID: 19923462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis resulting from liver-specific expression and recognition of self-antigen.
    Buxbaum J; Qian P; Allen PM; Peters MG
    J Autoimmun; 2008 Nov; 31(3):208-15. PubMed ID: 18513923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated natural killer T cells producing interferon-gamma elicit promoting activity to murine dendritic cell-based autoimmune hepatic inflammation.
    Nakano M; Saeki C; Takahashi H; Homma S; Tajiri H; Zeniya M
    Clin Exp Immunol; 2012 Dec; 170(3):274-82. PubMed ID: 23121668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma.
    Rothfuchs AG; Kreuger MR; Wigzell H; Rottenberg ME
    J Immunol; 2004 Feb; 172(4):2407-15. PubMed ID: 14764711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.